Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Amorfix and QED to co-develop high-affinity monoclonal antibodies for cancer

June 28, 2010

GSK and Prosensa expand development of DMD treatments

June 25, 2010

Medivir and GSK to market Xerclear for treatment of cold sores

June 25, 2010

Sanofi-aventis and Regulus collaborate on microRNA therapeutics

June 23, 2010

Exelixis regains rights to XL-184

June 22, 2010

CanBas and Takeda to terminate collaboration for anticancer agent CBP-501

June 21, 2010

Neurocrine and Boehringer to develop GPR119 agonists for type 2 diabetes

June 21, 2010

OncoMed and Bayer Schering form anticancer stem cell alliance

June 18, 2010

Abbott and Neurocrine join to develop elagolix for endometriosis

June 18, 2010

GIND and ISB join to identify genes and targets involved in Huntington's disease

June 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...